Access to hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant 2010 Aug;16(8):1070-5
Date
12/29/2009Pubmed ID
20036337Pubmed Central ID
PMC3144674DOI
10.1016/j.bbmt.2009.12.529Scopus ID
2-s2.0-77954311007 (requires institutional sign-in at Scopus site) 79 CitationsAbstract
Hematopoietic cell transplantation (HCT) is a highly specialized and resource-intense medical procedure that can be associated with disparities in access to transplantation. Barriers to access to HCT are multifactorial, complex, and interrelated. Our current knowledge of specific barriers that prevent access to HCT is very limited. As the utilization of HCT increases, it is imperative that underserved populations receive the benefit of this life-saving procedure. We review the prevailing literature on access to HCT and describe research priorities for eliminating disparities in transplantation. Better understanding of these complex barriers will minimize inequities, inform health policy, guide development of interventions targeted to eliminate disparities, and continue the expansion of HCT in the future.
Author List
Majhail NS, Omondi NA, Denzen E, Murphy EA, Rizzo JDAuthor
J. Douglas Rizzo MD, MS Director, Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Age FactorsHealth Services Accessibility
Hematopoietic Stem Cell Transplantation
Humans
United States